CBD Products - United States

United States

The CBD Products in the United States is forecasted to achieve a revenue of US$2.58bn by 2024.
This projection reflects a steady annual growth rate (CAGR 2024-2029) of -0.23%, which is anticipated to contribute to a market volume of US$2.55bn by 2029.
In terms of global comparison, in the United States is expected to generate the highest revenue in the CBD Products, amounting to US$2.58bn in 2024.
When considering the population figures, the per person revenue in 2024 is estimated to be US$18.29.
The United States is experiencing a growing trend in the therapeutic cannabis market as more states legalize its use for medicinal purposes.

Key regions: South Africa, Spain, Canada, Europe, Netherlands

Market

Region

Region comparison

Currency

Analyst Opinion

In recent years, the CBD Products market in the United States has experienced significant growth and evolution.

Customer preferences: Consumers in the United States have shown a growing interest in natural and alternative health remedies, leading to an increased demand for CBD products. There is a shift towards wellness and self-care, with many individuals seeking out CBD products for their potential health benefits.

Trends in the market: One notable trend in the CBD Products market in the United States is the diversification of product offerings. Companies are introducing a wide range of CBD-infused products, including skincare items, beverages, pet treats, and more. This diversification is catering to different consumer needs and preferences, driving further market growth.

Local special circumstances: The United States has a complex regulatory environment surrounding CBD products, with varying laws at the state and federal levels. This has created challenges for businesses operating in the market, leading to a fragmented landscape. Additionally, the presence of well-established wellness and beauty industries in the U. S. has influenced the marketing and distribution strategies of CBD product manufacturers.

Underlying macroeconomic factors: The growing acceptance and legalization of cannabis for medical and recreational use in several states have contributed to the expansion of the CBD market in the United States. Economic factors such as increasing disposable income and a focus on health and wellness have also played a role in driving consumer spending on CBD products. Moreover, the competitive landscape and presence of key players in the market have fostered innovation and product development to meet the evolving needs of customers.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.